Share This Page
Suppliers and packagers for generic pharmaceutical drug: povidone-iodine
✉ Email this page to a colleague
povidone-iodine
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Alcon Pharms Ltd | BETADINE | povidone-iodine | SOLUTION/DROPS;OPHTHALMIC | 018634 | NDA | Alcon Laboratories, Inc. | 0065-0411-30 | 1 BOTTLE in 1 CARTON (0065-0411-30) / 30 mL in 1 BOTTLE | 2000-04-01 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers and packagers for generic pharmaceutical drug: povidone-iodine
Povidone-Iodine Suppliers in the US and Global Marketplace: What to Buy, Who Makes It, and How Availability Constraints Affect Supply
Povidone-iodine (PVP-I) is a widely sourced, commodity-style antiseptic API/salt system, with procurement dominated by large chemical and specialty iodine manufacturers plus tollers that compound into branded finished dosage forms (solutions, swabs, scrubs, povidone-iodine gargles). Supply risk typically tracks (1) iodine feedstock availability and pricing, (2) quality system readiness for pharma-grade specifications, and (3) packaging line capacity for OTC and hospital-ready units.
Below is a market-usable supplier map focused on commercial procurement: API/povidone-iodine concentrate suppliers, contract manufacturers and formulators for dosage forms, and the main supplier categories that control lead times.
Who are the main suppliers of povidone-iodine (PVP-I) API and industrial grade?
The supplier base for povidone-iodine splits into two procurement paths: chemical producers that sell povidone-iodine as an API/intermediate or pharma-grade bulk, and toll/compounding suppliers that sell finished antiseptic dosage forms under brand and private label.
Common supplier categories
- Iodine/iodinated specialty chemical producers selling PVP-I as bulk chemical (concentrate or standardized solution).
- Polymer and iodination system specialists producing the povidone-iodine complex to defined iodine content specs.
- Global chemical distributors that supply pharma-grade lots for formulators and packagers.
- Finished dosage form manufacturers that buy standardized PVP-I bulk and package into OTC/hospital items.
Which companies supply pharma-grade povidone-iodine bulk for solution, scrub, and topical use?
In pharma procurement practice, “povidone-iodine supplier” often means the entity that sells controlled spec bulk meeting pharmacopoeial requirements (commonly BP/USP/Eur endpoints, including iodine content and microbial limits).
Procurement-ready supplier archetypes
- Large iodine value-chain players: control iodine input, production capacity, and standardization.
- Specialty chemical manufacturers: scale polymer-iodine complex production and offer documentation packages (GMP, CoA, specs, impurity profiles).
- Regional distributors: carry multiple producers, provide quick lot access, and support label/packaging partners.
What buyers typically request
- Iodine content target and range (standardized by supplier)
- USP/BP/Eur compliance documentation
- Residuals/impurities (free iodine, iodate, bound iodine profile)
- Microbiological limits
- GMP status for pharma-grade supply
What contract manufacturers make povidone-iodine solutions, swabs, and scrubs?
Dosage-form manufacturing is usually outsourced to compounding and packaging operations that can meet OTC and hospital product expectations. Contracts often include:
- filling and packaging into bottles, unit dose cups, and squeeze tubes
- producing swabsticks and wound dressing kits (often with applicator components)
- labeling, serialization, and distribution readiness
Key manufacturing steps that affect supplier qualification
- dilution standardization of bulk PVP-I
- solubilization and stabilization (excipient system)
- filtration strategy and hold times
- packaging compatibility (materials that prevent iodine loss or discoloration)
- stability data for labeled strength and shelf life
How does povidone-iodine supplier availability change lead times and pricing?
Supply is sensitive to iodine feedstock and iodination/standardization capacity. Lead times typically widen when:
- iodine feedstock becomes constrained
- multiple downstream packagers increase seasonal demand (hospital infection control cycles and OTC peak periods)
- quality audit timelines extend for new lots or new sites
Pricing drivers
- iodine raw material pricing
- standardization cost (titration and iodine content control)
- compliance and documentation overhead (GMP batch record readiness)
- packaging scale constraints (bottle and swab line availability)
What quality and regulatory documentation do povidone-iodine suppliers provide?
For pharma/OTC purchasers, supplier documentation is the gate. Typical procurement packages include:
- CoA with iodine content, identity, purity, and impurity profiles
- specification sheet for iodine range and acceptance criteria
- batch manufacturing records summary (site-dependent)
- GMP certificate or written confirmation of GMP manufacturing for pharma-grade supply
- stability summaries and packaging compatibility statements for finished goods
Regulatory interface (high-level)
- For OTC antiseptic products, regulatory status is product-specific, even when the API is widely sourced.
- For pharma-grade bulk, purchasers focus on pharmacopoeial compliance and GMP traceability.
Which countries and supply regions dominate povidone-iodine manufacturing?
Povidone-iodine supply is global, with manufacturing concentrated in regions that have established iodine chemistry infrastructure and polymer/iodination production capability. Procurement strategies often include:
- dual-sourcing across regions to hedge iodine feedstock volatility
- qualifying alternate packaging suppliers (containers, swabs, applicators) to prevent non-API shortages
Typical regional procurement approach
- US/EU-facing purchasers qualify at least one regional distributor plus a primary manufacturer source
- Global formulators keep 2 to 3 acceptable bulk producers to protect dilution and standardization consistency
What formulation systems affect povidone-iodine supplier selection (strength, excipients, and delivery format)?
Supplier choice changes based on the dosage form:
- Topical solutions require stable dilution behavior, consistent iodine content, and low variability in viscosity/appearance.
- Gargles need excipient systems that preserve iodine stability and minimize taste and irritation issues.
- Swabs depend on bulk uniformity and compatibility with applicator materials and packaging.
Key formulation constraints
- viscosity and dilution target
- compatible solubilizers and stabilizers
- packaging permeability and discoloration behavior
- shelf life performance for labeled concentration
What patent and exclusivity issues affect povidone-iodine suppliers?
For povidone-iodine, the market is generally treated as a well-established active with broad, non-blocking commercial supply. Supplier constraints are usually operational and quality driven, not tied to active ingredient exclusivity. In practice, the IP landscape impacts:
- proprietary excipient systems
- specific delivery devices (swab formats, wound kits)
- method-of-use or labeled indications for branded products
- manufacturing process variants (less common for commodity antiseptics)
How strong is the patent estate around povidone-iodine products, and does it restrict new entrants?
For povidone-iodine, competitive entry risk is typically low at the API level and higher at the product level (formulation, device, and label claims). New entrants focus on:
- matching pharmacopoeial quality
- demonstrating stability for their formulation
- regulatory pathway alignment for their finished product category
Generic entry risk for povidone-iodine products: what fails during commercialization?
Failures are usually not about patents; they are about:
- inability to secure consistent bulk PVP-I iodine content
- stability or discoloration issues in finished product
- packaging incompatibility
- late-stage QC nonconformance in antimicrobial performance tests
What supply chain bottlenecks most often disrupt povidone-iodine manufacturing?
Top disruption points:
- iodine feedstock availability and cost swings
- iodination/complex formation capacity constraints at bulk suppliers
- bottling and swab assembly lines during peak seasons
- packaging materials (container resins, applicators, closures) and lead times
- QC release bottlenecks for standardized iodine content testing
Supplier qualification checklist for povidone-iodine (API and finished dosage forms)
A practical, procurement-grade qualification package includes:
- Supplier GMP statement and site manufacturing scope
- CoA history (at least multiple recent lots)
- iodine content variability and acceptance criteria performance
- impurity profile and free iodine tolerance data
- microbiological testing approach and limits
- container/closure compatibility for the intended finished form
- traceability and deviation handling process
- stability protocol and data for labeled strength and shelf life target
Key Takeaways
- Povidone-iodine supply is typically commodity-like at the API level, with supplier choice dominated by iodine feedstock availability, standardization consistency, and GMP documentation readiness.
- Dosage-form packaging and device components (swabs, applicators, wound kits) create the operational bottlenecks that most often drive lead times.
- Patent-driven restrictions are usually not the main barrier for povidone-iodine entry; quality, stability, and packaging compatibility are the main commercial constraints.
FAQs
1) What spec differences matter most when comparing povidone-iodine suppliers?
Iodine content target/range, free iodine/impurity profiles, and lot-to-lot variability are the primary differentiators.
2) Can I source povidone-iodine from multiple suppliers without reformulation?
Often yes for standardized bulk, but QC must confirm iodine content, viscosity, and appearance behavior match incoming specifications before release testing.
3) What excipients most commonly cause stability issues in povidone-iodine solutions?
Compatibility is product-specific, but excipients that affect pH and oxidative environment can influence iodine stability and discoloration.
4) How do packaging materials affect povidone-iodine shelf life?
Container permeability and closure interactions can impact iodine stability and color, so packaging compatibility testing is a standard risk-control step.
5) What is the fastest path to continuity of supply for povidone-iodine products?
Dual-qualify bulk suppliers and add backup packaging lines or alternate closure/container options to reduce single-point failures.
References (APA)
- USP. (n.d.). United States Pharmacopeia monographs for povidone-iodine. United States Pharmacopeial Convention.
- European Pharmacopoeia. (n.d.). Povidone-iodine monographs. European Directorate for the Quality of Medicines & HealthCare.
- British Pharmacopoeia. (n.d.). Povidone-iodine monographs. Medicines and Healthcare products Regulatory Agency.
More… ↓
